Is there rebound psychosis on withdrawal of antipsychotic medication in schizophrenia?

被引：3
作者：
Taylor, Matthew J. [1 ,2 ]
Yim, Seb [1 ]
机构：
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England
[2] South London & Maudsley NHS Fdn Trust, Psychosis Clin Acad Grp, London SE5 8AZ, England
来源：
SCHIZOPHRENIA RESEARCH | 2018年 / 201卷
关键词：
RISK;
D O I：
10.1016/j.schres.2018.06.008
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：430 / 431
页数：2
相关论文
共 50 条
  • [41] In utero exposure to antipsychotic medication and psychiatric outcomes in the offspring
    Momen, Natalie C.
    Robakis, Thalia
    Liu, Xiaoqin
    Reichenberg, Abraham
    Bergink, Veerle
    Munk-Olsen, Trine
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (03) : 759 - 766
  • [42] An Attempt to Improve Antipsychotic Medication Adherence by Feedback of Medication Possession Ratio Scores to Prescribers
    Patel, Urvashi B.
    Ni, Quanhong
    Clayton, Carol
    Lam, Peter
    Parks, Joseph
    POPULATION HEALTH MANAGEMENT, 2010, 13 (05) : 269 - 274
  • [43] Personal Accounts of Discontinuing Neuroleptic Medication for Psychosis
    Le Geyt, Gabrielle
    Awenat, Yvonne
    Tai, Sara
    Haddock, Gillian
    QUALITATIVE HEALTH RESEARCH, 2017, 27 (04) : 559 - 572
  • [44] Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis
    Lambert, Tim
    AUSTRALIAN PRESCRIBER, 2011, 34 (04) : 97 - 99
  • [45] Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
    Lin, Yi-Ting
    Hwang, Tzung-Jeng
    Shan, Jia-Chi
    Chiang, Huey-Ling
    Sheu, Yi-Han
    Hwu, Hai-Gwo
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (02) : 147 - 153
  • [46] Medication Exposure and Mortality in Patients With Schizophrenia
    Brodeur, Sebastien
    Chiu, Yohann M.
    Courteau, Josiane
    Dorais, Marc
    Oliver, Dominic
    Stip, Emmanuel
    Fleury, Marie-Josee
    Roy, Marc-Andre
    Vanasse, Alain
    Lesage, Alain
    Leclerc, Jacinthe
    JAMA NETWORK OPEN, 2024, 7 (11)
  • [47] Medication impact on oral health in schizophrenia
    Urien, Leire
    Jauregizar, Nerea
    Lertxundi, Unax
    Fernandez, Unai
    Morera-Herreras, Teresa
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2024, 29 (01): : e51 - e57
  • [48] Guideline-Concordant Antipsychotic Use and Mortality in Schizophrenia
    Cullen, Bernadette A.
    McGinty, Emma E.
    Zhang, Yiyi
    dosReis, Susan C.
    Steinwachs, Donald M.
    Guallar, Eliseo
    Daumit, Gail L.
    SCHIZOPHRENIA BULLETIN, 2013, 39 (05) : 1159 - 1168
  • [49] Updated rationale for the initial antipsychotic selection for patients with schizophrenia
    Markota, Matej
    Morgan, Robert J.
    Leung, Jonathan G.
    SCHIZOPHRENIA, 2024, 10 (01)
  • [50] The stable patient with schizophrenia - From antipsychotic effectiveness to adherence
    Thomas, Pierre
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S115 - S122
12345